Introduction:
Introduction: Many new anti Many new anti--cancer drugs target kinase activity.
cancer drugs target kinase activity. Unfortunately, methods to monitor the drug effects at the Unfortunately, methods to monitor the drug effects at the enzymatic level in patient derived tumor tissue are lacking. enzymatic level in patient derived tumor tissue are lacking. Here, a novel molecular profiling method for application in Here, a novel molecular profiling method for application in biomarker discovery is presented. This method is based on biomarker discovery is presented. This method is based on measuring kinase activities in tumor tissue extracts, and measuring kinase activities in tumor tissue extracts, and involves assessment of inhibition by a drug of interest. This ex involves assessment of inhibition by a drug of interest. This ex vivo activity vivo activity--based approach is enabled by dynamic peptide based approach is enabled by dynamic peptide microarrays microarrays. These arrays comprise of peptides, which are . These arrays comprise of peptides, which are known substrates for known substrates for phosphorylation phosphorylation by protein by protein kinases kinases. Here . Here we investigated the applicability of this approach in the we investigated the applicability of this approach in the classification of multiple tumors of different origin. classification of multiple tumors of different origin. , NSCLC: gefitinib gefitinib). ).
Method

Results:
Results: We show here that from different tumors kinase activity profiles We show here that from different tumors kinase activity profiles could be generated reproducibly (10 could be generated reproducibly (10--15% CV for selected 15% CV for selected peptides). Control experiments showed protein concentration peptides). Control experiments showed protein concentration and ATP dependency. In the RCC experiments different and ATP dependency. In the RCC experiments different phosphorylation phosphorylation profiles were obtained when the non profiles were obtained when the non--tumor tumor tissue was compared to tumor tissue derived from the same tissue was compared to tumor tissue derived from the same patient, showing higher kinase activities in the latter. In patient, showing higher kinase activities in the latter. In addition, inhibitor dependent modulation of the peptide addition, inhibitor dependent modulation of the peptide phosphorylations phosphorylations was observed ( was observed (sorafenib sorafenib vs. vs. sunitinib sunitinib). ). Furthermore, differential kinase activity profiles were obtained Furthermore, differential kinase activity profiles were obtained that could be correlated to different patient subgroups (BC) or that could be correlated to different patient subgroups (BC) or clinical data (long vs. short term survivors; NSCLC). clinical data (long vs. short term survivors; NSCLC).
Conclusion: Conclusion:
A novel molecular profiling approach was successfully applied A novel molecular profiling approach was successfully applied for classification of different tumors. This approach is based o for classification of different tumors. This approach is based on n detection of kinase activities as well as inhibition of kinase detection of kinase activities as well as inhibition of kinase activity in tumor tissues. Application of this method in the activity in tumor tissues. Application of this method in the discovery of biomarkers for diagnosis, prognosis or prediction discovery of biomarkers for diagnosis, prognosis or prediction of drug response is foreseen. of drug response is foreseen. 
